| 1. |
- Dahle, Nina Edel, et al.
(författare)
-
Emoqol- 100 : Development and validation of a single question for low mood in primary care. A retrospective audit.
- 2023
-
Ingår i: BJGP OPEN. - : Royal College of General Practitioners. - 2398-3795. ; 7:3
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Patients with depression need to be diagnosed and managed effectively in primary care. However, current inventories for case- finding low mood are time- consuming when considering the limited time available during appointments. Aim: To validate the diagnostic accuracy of a single question on the emotional quality of life (Emoqol- 100) as a measure of depression in symptomatic patients. Design & setting: A retrospective clinical audit, validating the Emoqol- 100 compared with the 9- item Patient Health Questionnaire (PHQ- 9) and Burns Depression Scale Today (BDST) in South Auckland, Method: Consecutive patients with suspected low mood, seen over 22 months in a single primary care clinic by one of the authors, were eligible for this retrospective audit (n = 160). The index test was the verbally asked Emoqol- 100: 'How is your emotional quality of life now, with 100 being perfect and 0 being the worst imaginable?' The reference standard was the PHQ- 9 (n = 426 visits) with a cut- off point of >= 10 or BDST (n = 513 visits) with a cut- off point of >= 6. Results: The Emoqol- 100 range 0-20 had a likelihood ratio (LR) of 25.2 for low mood compared with the BDST as the reference standard; and for Emoqol- 100 scores of 21-40, 41-60, 61-80, and 81-100 the LRs were 3.6, 1.7, 0.35, and 0.09, respectively. For the PHQ- 9, these were 10.1, 2.9, 1.3, 0.40, and 0.2, respectively. Any score <= 60 was associated with a low mood. Conclusion: The Emoqol- 100 appears to have high validity, so when it is low (<= 60), it is suggestive of a high PHQ- 9 or BDST score, and a mood issue probably exists. Emoqol- 100 could be helpful for busy primary care professionals and other clinicians.
|
|
| 2. |
- Feigin, Valery L., et al.
(författare)
-
Usability and feasibility of PreventS-MD web app for stroke prevention
- 2024
-
Ingår i: International Journal of Stroke. - 1747-4930. ; 19:1, s. 94-104
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Most strokes and cardiovascular diseases (CVDs) are potentially preventable if their risk factors are identified and well controlled. Digital platforms, such as the PreventS-MD web app (PreventS-MD) may aid health care professionals (HCPs) in assessing and managing risk factors and promoting lifestyle changes for their patients. Methods: This is a mixed-methods cross-sectional two-phase survey using a largely positivist (quantitative and qualitative) framework. During Phase 1, a prototype of PreventS-MD was tested internationally by 59 of 69 consenting HCPs of different backgrounds, age, sex, working experience, and specialties using hypothetical data. Collected comments/suggestions from the study HCPs in Phase 1 were reviewed and implemented. In Phase 2, a near-final version of PreventS-MD was developed and tested by 58 of 72 consenting HCPs using both hypothetical and real patient (n = 10) data. Qualitative semi-structured interviews with real patients (n = 10) were conducted, and 1 month adherence to the preventive recommendations was assessed by self-reporting. The four System Usability Scale (SUS) groups of scores (0–50 unacceptable; 51–68 poor; 68–80.3 good; >80.3 excellent) were used to determine usability of PreventS-MD. Findings: Ninety-nine HCPs from 27 countries (45% from low- to middle-income countries) participated in the study, and out of them, 10 HCPs were involved in the development of PreventS before the study, and therefore were not involved in the survey. Of the remaining 89 HCPs, 69 consented to the first phase of the survey, and 59 of them completed the first phase of the survey (response rate 86%), and 58 completed the second phase of the survey (response rate 84%). The SUS scores supported good usability of the prototype (mean score = 80.2; 95% CI [77.0–84.0]) and excellent usability of the final version of PreventS-MD (mean score = 81.7; 95% CI [79.1–84.3]) in the field. Scores were not affected by the age, sex, working experience, or specialty of the HCPs. One-month follow-up of the patients confirmed the high level of satisfaction/acceptability of PreventS-MD and (100%) adherence to the recommendations. Interpretation: The PreventS-MD web app has a high level of usability, feasibility, and satisfaction by HCPs and individuals at risk of stroke/CVD. Individuals at risk of stroke/CVD demonstrated a high level of confidence and motivation in following and adhering to preventive recommendations generated by PreventS-MD. © 2023 World Stroke Organization.
|
|
| 3. |
- Matthew, Carolyn, et al.
(författare)
-
Burns Depression Scale Today (BDST) : A validation study of BDST against the reference standard of PHQ-9
- 2023
-
Ingår i: JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE. - : Wolters Kluwer. - 2249-4863 .- 2278-7135. ; 12:7, s. 1367-1370
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Case finding for low mood is essential in primary care, but it is time-consuming using current depression inventories. The Burns Depression Scale Today (BDST) is a short, simple inventory which assesses mood for today, and we aimed to validate it in this study.Materials and Methods: Consecutive patients with emotional distress seen in a single primary care clinic by one of the authors over 22 months were eligible for this retrospective audit (N = 160). Multiple visits (N = 421) from the same patient were included in the study. The index test was BDST, which assesses the patient's mood for today. The reference standard was the 9-item Patient Health Questionnaire (PHQ-9), which assesses mood over the past 2 weeks. PHQ-9 had a cut-off point of & GE;10 and BDST had a cut-off point of & GE;6 for a significant mood issue.Results: The median age of patients was 35 years, and 63% of the cohort were women. The median BDST score was 8, indicative of moderately low mood, and the median PHQ-9 score was 15, indicative of moderately severe depression. For patients with a BDST score & GE;6, the likelihood ratio of a positive test was 2.67. The sensitivity was 85% (95% confidence interval [CI]: 89%-96%) and the specificity was 68% (95% CI: 60%-76%). The area under the curve was 84% (95% CI: 80%-87%).Conclusion: This audit validates BDST against PHQ-9 and finds it an excellent case-finding tool compared to PHQ-9. This is the first validation study of BDST.
|
|
